Longevity clinics charge $5,000 to $25,000 a year.
Most of that is concierge access and lab markups, not medication.
Rapamycin. Metformin. GLP-1 microdosing where appropriate. Plus the labs that tell you whether any of it is working. Clinician-reviewed. Transparently priced.

Most of that is concierge access and lab markups, not medication.
Most of what people pay for has no good evidence. The few molecules with real human data are hard to access.
Off-label use of rapamycin, metformin, or low-dose naltrexone for healthspan isn't something most PCPs will engage with.
| Den Health | In-clinic / telehealth | DIY / supplements | |
|---|---|---|---|
| Price | From $149 / month | $200–$500 / month | Low, but inconsistent |
| Cash-pay, no insurance games | |||
| Licensed clinician review where required | Yes (and slow) | ||
| Pharmacy-fulfilled medication where supported | Yes | ||
| Continuity of care | Inconsistent | ||
| No upsells, no surprise charges | N/A |
Our long-term thesis is that automated pharmacy operations and a focused clinical workflow deliver the same quality of care at a meaningfully lower price. The number to the right is what we're targeting.
No payment to start. Treatment is subject to clinician review.
No call trees. No surprise charges. No 30-day-supply-of-melatonin upsells.
Most healthcare invoices are a black box. Here's where the typical month's cost actually lives, and how we keep ours below market.
The clinical thinking behind longevity & preventative health. Not marketing. The actual literature we'd build on.
Low-dose, intermittent weekly dosing protocols show favorable safety profiles and biological signals in immune and metabolic function.
Source: Mannick et al., Sci Transl Med, 2018
Many popular IV and injectable interventions (high-dose NAD, peptide stacks) have promising mouse data and limited human RCTs. We err toward molecules with the strongest evidence.
Source: Nature Aging, multiple reviews
Metformin, low-dose naltrexone, and rapamycin are all FDA-approved for other indications with well-characterized safety profiles. A clinician would evaluate fit individually.
Source: Long-running clinical use, multiple indications
Den Health serves longevity & preventative health patients across the US. We add new states as we expand. Submit an intake to confirm availability in yours.
“I'd been paying $300 a session at a ketamine clinic. The math never worked. Hearing someone is finally building this at a real price made me sign up the same day.”

“My OB told me to ride out perimenopause. I'm not riding anything out. Give me a clinician who knows modern HRT and a price that isn't predatory.”

“I've been on three different telehealth platforms for anxiety. Different prescriber every time, six-minute visits, refill gaps. Just give me one clinician and a flat price.”

Patients on the longevity & preventative health program. Real people, real prescriptions, in supported states.






Healthcare is one of the few industries where the price you pay has almost nothing to do with what something costs to make. We're operators and clinicians who got tired of explaining that to our families.
Den Health is the company we wanted to build. A vertically integrated cash-pay pharmacy. Automation where it makes sense. Clinicians where it matters. The difference goes to patients.
Five programs today. Cash-pay only. One price per month. Roughly 30% below the market we replace.
Anything else you want to know? You can ask in the intake. We read every response.
Off-label, low-dose, weekly rapamycin has a growing body of human data and an established safety profile in transplant patients at much higher doses. It's not appropriate for everyone, especially around active infection, surgery, or pregnancy. A clinician reviews your situation.
No payment. No spam. Honest answers help us build the program that's worth shipping.
Submitting an intake does not establish a clinician-patient relationship until a licensed clinician reviews your information.